Funding to Help Further Clinical Development of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic ...
Enhanced ADCC activity of FPA144 may play an important mechanistic role in anti-tumor efficacy ...
Helomics Holding Corporation, predicted to generate approximately $3.2 million in revenues by the end ...
